Structures by: Singh A. N.
Total: 13
6,8-dinitro-2,4-dihydro-1<i>H</i>- benzo[<i>b</i>][1,2,4]triazolo[4,3-<i>d</i>][1,4]oxazin-1-one
C9H5N5O6
Acta Crystallographica Section C (2012) 68, 8 o302-o307
a=6.6313(4)Å b=18.5174(11)Å c=8.3354(5)Å
α=90.00° β=91.3520(10)° γ=90.00°
(<i>E</i>)-2-(2-hydroxy-4-oxopent-2-en-3-yl)-6,8-dinitro-2,4-dihydro- 1<i>H</i>-benzo[<i>b</i>][1,2,4]triazolo[4,3-<i>d</i>][1,4]oxazin-1-one
C14H11N5O8
Acta Crystallographica Section C (2012) 68, 8 o302-o307
a=7.2636(8)Å b=17.673(2)Å c=12.0447(13)Å
α=90.00° β=90.00° γ=90.00°
Erlotinib hemioxalate
2(C22H24N3O4),C2O42
Acta Crystallographica Section C (2010) 66, 1 o33-o38
a=7.6285(8)Å b=10.2252(10)Å c=14.6525(14)Å
α=86.076(2)° β=84.925(2)° γ=70.559(2)°
Erlotinib monohydrate
C22H23N3O4,H2O
Acta Crystallographica Section C (2010) 66, 1 o33-o38
a=9.0227(10)Å b=10.4548(11)Å c=13.2014(14)Å
α=98.705(2)° β=108.738(2)° γ=111.873(2)°
Erlotinib fumaric acid hemisolvate dihydrate
C22H23N3O4,0.5(C4H4O4),2(H2O)
Acta Crystallographica Section C (2010) 66, 1 o33-o38
a=7.967(2)Å b=13.248(4)Å c=13.745(4)Å
α=108.916(5)° β=106.673(5)° γ=101.909(5)°
4<i>H</i>-1,2,4-Triazolo[3,4-<i>c</i>][1,4]benzothiazin-1(2<i>H</i>)-one
C9H7N3OS
Acta Crystallographica Section C (2012) 68, 11 o475-o480
a=14.6307(11)Å b=8.5718(7)Å c=28.083(2)Å
α=90.00° β=90.00° γ=90.00°
2-(2-Oxo-2-phenylethyl)-4<i>H</i>-1,2,4-triazolo[3,4- <i>c</i>][1,4]benzothiazin-1(2<i>H</i>)-one
C17H13N3O2S
Acta Crystallographica Section C (2012) 68, 11 o475-o480
a=11.6248(18)Å b=14.920(2)Å c=8.5909(13)Å
α=90.00° β=102.564(3)° γ=90.00°
Ethyl 3-oxo-2-(1-oxo-1<i>H</i>,4<i>H</i>-1,2,4-triazolo[3,4- <i>c</i>][1,4]benzothiazin-2-yl)-3-phenylpropanoate
C20H17N3O4S
Acta Crystallographica Section C (2012) 68, 11 o475-o480
a=13.6533(14)Å b=12.7279(13)Å c=22.2927(19)Å
α=90.00° β=100.601(3)° γ=90.00°
Eletriptan hydrobromide monohydrate
C22H27N2O2S,Br,H2O
Acta Crystallographica Section C (2008) 64, 12 o653-o656
a=9.4019(6)Å b=13.4089(8)Å c=18.0173(11)Å
α=90.00° β=90.00° γ=90.00°
Naratriptan hydrochloride
C17H26N3O2S,Cl
Acta Crystallographica Section C (2008) 64, 12 o653-o656
a=6.1914(5)Å b=12.2298(10)Å c=12.9948(11)Å
α=78.3480(10)° β=76.3380(10)° γ=86.0330(10)°
Almotriptan
C17H25N3O2S
Acta Crystallographica Section C (2008) 64, 1 o15-o17
a=20.5023(17)Å b=7.6894(6)Å c=22.8470(19)Å
α=90.00° β=104.904(2)° γ=90.00°
Almotriptan Malate
C17H26N3O2S,C4H5O5
Acta Crystallographica Section C (2008) 64, 1 o15-o17
a=7.5542(7)Å b=9.3561(9)Å c=17.3608(17)Å
α=104.081(2)° β=101.121(2)° γ=92.681(2)°
C30H31N3
C30H31N3
Journal of Organic Chemistry (2008) 73, 6513-6520
a=11.888(1)Å b=14.020(2)Å c=16.414(3)Å
α=64.843(2)° β=86.835(4)° γ=82.569(2)°